Literature DB >> 1355852

Type 1 pili enhance the invasion of Salmonella braenderup and Salmonella typhimurium to HeLa cells.

S Horiuchi1, Y Inagaki, N Okamura, R Nakaya, N Yamamoto.   

Abstract

The relationship between type 1 pili-associated adhesion and invasion to HeLa cells by Salmonella braenderup and S. typhimurium was studied. When the clinical isolates of these strains were grown in L-broth, they showed both type 1 pili formation and mannose-sensitive adhesion to HeLa cells. On the other hand, the type 1 pili-defective mutants, which were obtained either by repeated subcultures on L-agar plates or by the transposon Tn1-insertion mutagenesis of the S. braenderup and S. typhimurium strains, concomitantly lost mannose-sensitive adhesion to HeLa cells. When the HeLa cells were incubated with Salmonella, the type 1 piliated strains invaded the HeLa cells with much higher infection rate than did the type 1 pili-defective strains. The invasion of type 1 piliated strains to HeLa cells was markedly inhibited in the presence of D-mannose. The infectivity of the strain, which lost type 1 pili but still had mannose-resistant adhesion, was slightly higher than that of the strains defective in both mannose-sensitive and mannose-resistant adhesion. These results suggested that type 1 pili have a role in enhancing the invasion of S. braenderup and S. typhimurium to HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355852     DOI: 10.1111/j.1348-0421.1992.tb02059.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  14 in total

Review 1.  Evolution of host adaptation in Salmonella enterica.

Authors:  A J Bäumler; R M Tsolis; T A Ficht; L G Adams
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

2.  FimW is a negative regulator affecting type 1 fimbrial expression in Salmonella enterica serovar typhimurium.

Authors:  J K Tinker; L S Hancox; S Clegg
Journal:  J Bacteriol       Date:  2001-01       Impact factor: 3.490

3.  Role of cross talk in regulating the dynamic expression of the flagellar Salmonella pathogenicity island 1 and type 1 fimbrial genes.

Authors:  Supreet Saini; James M Slauch; Phillip D Aldridge; Christopher V Rao
Journal:  J Bacteriol       Date:  2010-09-10       Impact factor: 3.490

4.  Salmonella enterica serovar typhi modulates cell surface expression of its receptor, the cystic fibrosis transmembrane conductance regulator, on the intestinal epithelium.

Authors:  Jeffrey B Lyczak; Gerald B Pier
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  Characterization of FimY as a coactivator of type 1 fimbrial expression in Salmonella enterica serovar Typhimurium.

Authors:  J K Tinker; S Clegg
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Salmonella Fimbrial Protein FimH Is Involved in Expression of Proinflammatory Cytokines in a Toll-Like Receptor 4-Dependent Manner.

Authors:  Kei-Ichi Uchiya; Yurie Kamimura; Ayumi Jusakon; Toshiaki Nikai
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

7.  DNA-based diagnostic tests for Salmonella species targeting agfA, the structural gene for thin, aggregative fimbriae.

Authors:  J L Doran; S K Collinson; J Burian; G Sarlós; E C Todd; C K Munro; C M Kay; P A Banser; P I Peterkin; W W Kay
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

8.  Association with MDCK epithelial cells by Salmonella typhimurium is reduced during utilization of carbohydrates.

Authors:  D A Schiemann
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Pathogenicity of dodecyltrimethylammonium chloride-resistant Salmonella enterica.

Authors:  Megan J M Kautz; Aleksey Dvorzhinskiy; Jonathan G Frye; Natalie Stevenson; Diane S Herson
Journal:  Appl Environ Microbiol       Date:  2013-02-01       Impact factor: 4.792

10.  Contribution of fimbrial operons to attachment to and invasion of epithelial cell lines by Salmonella typhimurium.

Authors:  A J Bäumler; R M Tsolis; F Heffron
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.